A steady, 25-year decline has resulted in a 27 percent drop in the overall cancer death rate in the United States, translating to approximately 2.6 million fewer cancer deaths between 1991 and 2016.
from Women's Health News -- ScienceDaily http://bit.ly/2Hcg7JU
Wednesday, January 9, 2019
Tuesday, January 8, 2019
Hormone therapy may be best defense against knee osteoarthritis
There is an ongoing debate regarding the relationship between knee osteoarthritis and hormone therapy (HT), with small-scale studies providing mixed results. A new large-scale study from Korea shows that women receiving HT had a significantly lower prevalence of symptomatic knee osteoarthritis compared with women who did not take hormones.
from Women's Health News -- ScienceDaily http://bit.ly/2FmyGbL
from Women's Health News -- ScienceDaily http://bit.ly/2FmyGbL
Hormone therapy may be best defense against knee osteoarthritis
There is an ongoing debate regarding the relationship between knee osteoarthritis and hormone therapy (HT), with small-scale studies providing mixed results. A new large-scale study from Korea shows that women receiving HT had a significantly lower prevalence of symptomatic knee osteoarthritis compared with women who did not take hormones.
from Women's Health News -- ScienceDaily http://bit.ly/2FmyGbL
from Women's Health News -- ScienceDaily http://bit.ly/2FmyGbL
Friday, January 4, 2019
Genetic testing does not cause undue worry for breast cancer patients
As genetic testing for breast cancer has become more complex, evaluating a panel of multiple genes, it introduces more uncertainty about the results. But a new study finds that newer, more extensive tests are not causing patients to worry more about their cancer risk.
from Women's Health News -- ScienceDaily http://bit.ly/2CRH3KJ
from Women's Health News -- ScienceDaily http://bit.ly/2CRH3KJ
Genetic testing does not cause undue worry for breast cancer patients
As genetic testing for breast cancer has become more complex, evaluating a panel of multiple genes, it introduces more uncertainty about the results. But a new study finds that newer, more extensive tests are not causing patients to worry more about their cancer risk.
from Breast Cancer News -- ScienceDaily http://bit.ly/2CRH3KJ
from Breast Cancer News -- ScienceDaily http://bit.ly/2CRH3KJ
Genetic testing does not cause undue worry for breast cancer patients
As genetic testing for breast cancer has become more complex, evaluating a panel of multiple genes, it introduces more uncertainty about the results. But a new study finds that newer, more extensive tests are not causing patients to worry more about their cancer risk.
from Women's Health News -- ScienceDaily http://bit.ly/2CRH3KJ
from Women's Health News -- ScienceDaily http://bit.ly/2CRH3KJ
Thursday, January 3, 2019
Experimental treatment shows promise against triple-negative breast cancer
A naturally occurring protein called Tinagl1 reduced the spread of triple-negative breast cancer in a study conducted in mice.
from Women's Health News -- ScienceDaily http://bit.ly/2VvoKCr
from Women's Health News -- ScienceDaily http://bit.ly/2VvoKCr
Experimental treatment shows promise against triple-negative breast cancer
A naturally occurring protein called Tinagl1 reduced the spread of triple-negative breast cancer in a study conducted in mice.
from Women's Health News -- ScienceDaily http://bit.ly/2VvoKCr
from Women's Health News -- ScienceDaily http://bit.ly/2VvoKCr
Experimental treatment shows promise against triple-negative breast cancer
A naturally occurring protein called Tinagl1 reduced the spread of triple-negative breast cancer in a study conducted in mice.
from Breast Cancer News -- ScienceDaily http://bit.ly/2VvoKCr
from Breast Cancer News -- ScienceDaily http://bit.ly/2VvoKCr
Persistent hot flashes may lead to increased risk of breast cancer
Studies examining the association between vasomotor symptoms (VMS) and breast cancer are not new, but results have been inconsistent. A new larger-scale study concludes that women participating in the Women's Health Initiative (WHI) trials who had persistent VMS are more likely to be diagnosed with breast cancer than women who never experienced VMS.
from Breast Cancer News -- ScienceDaily http://bit.ly/2Syxt4B
from Breast Cancer News -- ScienceDaily http://bit.ly/2Syxt4B
Subscribe to:
Posts (Atom)